Andreas Katopodis

2.9k total citations
59 papers, 1.8k citations indexed

About

Andreas Katopodis is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Andreas Katopodis has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Surgery and 14 papers in Organic Chemistry. Recurrent topics in Andreas Katopodis's work include Glycosylation and Glycoproteins Research (15 papers), Xenotransplantation and immune response (15 papers) and Carbohydrate Chemistry and Synthesis (13 papers). Andreas Katopodis is often cited by papers focused on Glycosylation and Glycoproteins Research (15 papers), Xenotransplantation and immune response (15 papers) and Carbohydrate Chemistry and Synthesis (13 papers). Andreas Katopodis collaborates with scholars based in Switzerland, United States and United Kingdom. Andreas Katopodis's co-authors include Sheldon W. May, Frank Kolbinger, Jürgen Fritz, Dario Anselmetti, Markus Streiff, Gebhard Thoma, Rudolf O. Duthaler, Beat Ernst, Reinhold Öhrlein and Gabi Baisch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Andreas Katopodis

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Katopodis Switzerland	23	897	305	303	282	260	59	1.8k
Tetsuya Yamamoto Japan	30	1.6k 1.8×	67 0.2×	505 1.7×	275 1.0×	95 0.4×	95	2.6k
Angela M. Otto Germany	26	920 1.0×	469 1.5×	134 0.4×	72 0.3×	44 0.2×	84	2.3k
Herbert Treutlein Australia	20	1.2k 1.3×	63 0.2×	220 0.7×	84 0.3×	120 0.5×	37	1.9k
Manuel E. Than Germany	27	1.9k 2.1×	93 0.3×	158 0.5×	127 0.5×	56 0.2×	54	3.1k
Wonhwa Cho United States	33	2.4k 2.7×	216 0.7×	340 1.1×	64 0.2×	70 0.3×	63	3.0k
Weiping Jiang United States	26	1.2k 1.4×	65 0.2×	239 0.8×	66 0.2×	101 0.4×	83	2.2k
Niamh Moran Ireland	25	916 1.0×	174 0.6×	301 1.0×	104 0.4×	21 0.1×	75	2.2k
Salem Faham United States	22	3.0k 3.3×	158 0.5×	106 0.3×	184 0.7×	108 0.4×	30	3.7k
Massimo De Paoli Italy	23	1.1k 1.3×	173 0.6×	135 0.4×	54 0.2×	56 0.2×	54	2.1k
Steven W. Dodd United States	17	1.5k 1.7×	69 0.2×	179 0.6×	139 0.5×	292 1.1×	25	2.0k

Countries citing papers authored by Andreas Katopodis

Since Specialization

Citations

This map shows the geographic impact of Andreas Katopodis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Katopodis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Katopodis more than expected).

Fields of papers citing papers by Andreas Katopodis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Katopodis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Katopodis. The network helps show where Andreas Katopodis may publish in the future.

Co-authorship network of co-authors of Andreas Katopodis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Katopodis. A scholar is included among the top collaborators of Andreas Katopodis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Katopodis. Andreas Katopodis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Egli, Nicole, et al.. (2025). ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy. Journal for ImmunoTherapy of Cancer. 13(7). e011905–e011905. 2 indexed citations

Hermann‐Kleiter, Natascha, Marlies Meisel, Friedrich Fresser, et al.. (2012). Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter. Journal of Autoimmunity. 39(4). 428–440. 40 indexed citations

Duthaler, Rudolf O., Beat Ernst, Andreas Katopodis, et al.. (2010). In vivo Neutralization of Naturally Existing Antibodies against Linear ?(1,3)-Galactosidic Carbohydrate Epitopes by Multivalent Antigen Presentation: A Solution for the First Hurdle of Pig-to-Human Xenotransplantation. CHIMIA International Journal for Chemistry. 64(1-2). 23–23. 4 indexed citations

Metzler, Barbara, Grazyna Wieczorek, Jianping Li, et al.. (2008). Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure. International Immunology. 20(5). 633–644. 28 indexed citations

Metzler, Barbara, et al.. (2008). Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin. Transplant Immunology. 20(1-2). 106–112. 5 indexed citations

Soleimani, Behzad, Grazyna Wieczorek, Andreas Katopodis, et al.. (2007). Anti–LFA-1 Monotherapy Prevents Neointimal Formation in a Murine Model of Transplant Intimal Hyperplasia. The Journal of Heart and Lung Transplantation. 26(7). 724–731. 4 indexed citations

Thoma, Gebhard, Markus Streiff, Andreas Katopodis, et al.. (2005). Non‐Covalent Polyvalent Ligands by Self‐Assembly of Small Glycodendrimers: A Novel Concept for the Inhibition of Polyvalent Carbohydrate–Protein Interactions In Vitro and In Vivo. Chemistry - A European Journal. 12(1). 99–117. 31 indexed citations

Kuwaki, Kenji, Christoph Knosalla, Kathleen Moran, et al.. (2004). Reduction of anti‐Galα1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly‐l‐lysine. Xenotransplantation. 11(2). 210–215. 16 indexed citations

Lam, Tuan T., Bernard Hausen, Julian P. T. Higgins, et al.. (2004). The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF‐transgenic pig‐to‐primate life‐supporting kidney xenografts. Xenotransplantation. 12(1). 20–29. 23 indexed citations

10.

Máñez, Rafael, Nieves Doménech, Alberto Centeno, et al.. (2004). Failure to deplete anti‐Galα1‐3Gal antibodies after pig‐to‐baboon organ xenotransplantation by immunoaffinity columns containing multiple Galα1‐3Gal oligosaccharides. Xenotransplantation. 11(5). 408–415. 13 indexed citations

11.

Zhong, Robert, Yigang Luo, Hongji Yang, et al.. (2003). Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of ??gal1. Transplantation. 75(1). 10–19. 40 indexed citations

12.

Alwayn, Ian P.J., Léo H. Bühler, Bernd Gollackner, et al.. (2003). Depletion of anti‐Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons. Xenotransplantation. 10(4). 357–367. 12 indexed citations

13.

Juffé, Alberto, Francisco Arnal, Emanuele Cozzi, et al.. (2000). Neutralization of anti-αGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons. Transplantation Proceedings. 32(5). 888–889. 12 indexed citations

14.

Blanco, Francisco J., et al.. (1999). Sustained decrease of serum anti-galactose α1–3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel. Transplantation Proceedings. 31(1-2). 947–948. 1 indexed citations

15.

Kolbinger, Frank, Markus Streiff, & Andreas Katopodis. (1998). Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-d-glucose 3β-Galactosyltransferase Catalyzing the Formation of Type 1 Chains. Journal of Biological Chemistry. 273(1). 433–440. 50 indexed citations

16.

Noe, Bryan D., Andreas Katopodis, & Sheldon W. May. (1991). Kinetic analyses of peptidylglycine α-amidating monooxygenase from pancreatic islets. General and Comparative Endocrinology. 83(2). 183–192. 3 indexed citations

17.

Katopodis, Andreas, et al.. (1991). Functional and structural characterization of peptidylamidoglycolate lyase, the enzyme catalyzing the second step in peptide amidation. Biochemistry. 30(25). 6189–6194. 41 indexed citations

18.

Katopodis, Andreas & Sheldon W. May. (1990). Novel substrates and inhibitors of peptidylglycine .alpha.-amidating monooxygenase. Biochemistry. 29(19). 4541–4548. 83 indexed citations

19.

Katopodis, Andreas, et al.. (1990). A novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of .alpha.-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine .alpha.-amidating monooxygenase in peptide amidation. Biochemistry. 29(26). 6115–6120. 122 indexed citations

20.

Katopodis, Andreas & Sheldon W. May. (1988). A new facile trinitrophenylated substrate for peptide α-amidation and its use to characterize PAM activity in chromaffin granules. Biochemical and Biophysical Research Communications. 151(1). 499–505. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact